CVS

CVS Health Corporation

NYSEUSDEQUITY DELAYED

93.12

▼ 0.53 (0.56%)

MARKET · —

Price

Open

93.65

Prev close

93.65

Day high

94.39

Day low

92.35

Volume

5.59M

Market cap

—

P/E (TTM)

—

52W range

69.51 – 110.68

Trailing performance

Price return · vs SPY

Returnvs SPY

-4.26% -2.9%

-12.98% -16.7%

-0.32% -3.4%

+21.29% +10.2%

YTD

+17.21% +4.9%

+31.35% +11.3%

+27.92% -46.3%

— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Fundamentals

TTM · reported

Market cap—

Enterprise value—

Revenue (TTM)—

Gross profit—

EBITDA—

Net income—

EPS (TTM)—

Free cash flow—

Total cash—

Total debt—

Book value / share—

Shares outstanding—

Float—

Short % of float—

Dividend yield—

Beta (5Y)—

Valuation & profitability ratios

Account required

Trailing P/E—

Forward P/E—

PEG ratio—

Price / sales—

Price / book—

EV / revenue—

EV / EBITDA—

Gross margin—

Operating margin—

Profit margin—

Return on equity—

Return on assets—

Debt / equity—

Current ratio—

Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Create free account Sign in

Analyst targets & ownership

Account required

Mean target—

High target—

Low target—

Implied upside—

Analyst count—

Consensus—

Strong buy / Buy— / —

Hold—

Sell / Strong sell— / —

Held by insiders—

Held by institutions—

Institutions holding—

Free account required

Price targets, consensus spread, insider and institutional ownership.

Create free account Sign in

Moving averages & technicals

Computed from 2Y daily closes

SMA 10

94.53

-1.49% from price

SMA 20

98.90

-5.95% from price

SMA 50

102.01

-8.81% from price

SMA 100

93.84

-0.77% from price

SMA 200

85.74

+8.49% from price

EMA 12

95.76

-2.75% from price

EMA 26

98.50

-5.46% from price

EMA 50

98.70

-5.64% from price

RSI (14)

34.1

Neutral

MACD (12,26,9)

-2.74

Hist -0.58

ATR (14)

2.99

3.22% of price

Realised vol 30D

28.2%

Annualised

Bollinger upper

109.77

20, 2σ

Bollinger lower

88.04

20, 2σ

50 / 200 cross

Golden

102.01 vs 85.74

Trend bias

Above 200

+8.49%

Risk profile

Daily returns · 1Y window

Beta vs SPY

0.17

Less volatile than market

Correlation to SPY

0.07

Largely independent

Realised vol 30D

28.2%

Annualised

Market vol 1Y

12.9%

SPY, annualised

Max drawdown 1Y

-16.4%

Peak to trough

Max drawdown 5Y

-60.5%

Peak to trough

ATR 14

2.99

3.22% of price

Beta (reported)

—

5Y monthly, from filing

Options chain

Account required

ExpirySpot 93.12

Calls

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Puts

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Create free account Sign in

Headlines

CVS · links out to the publisher

Is The Pullback In UNH Stock A Glitch Or A Warning? Trefis · 13h ago Mark Cuban: “No Chance” Radiologists Get Replaced by AI. He Says the Real Target Is Elsewhere 24/7 Wall St. · 13h ago CVS Health: Every Community Deserves a Healthier Heart ACCESS Newswire · 20h ago Hims & Hers Health Stock Trades Below The Market On Revenue And Above It On Cash Trefis · 2d ago Temporary Mobile CVS Pharmacy Helps Restore Pharmacy Access in Pawling, NY, Following Fire ACCESS Newswire · 2d ago Prescription Drugs — Not Broke Consumers — Caused Walmart’s Big Sales Whiff 24/7 Wall St. · 2d ago Can CVS Health (CVS) Stay Below Fair Value After Strong Results? Simply Wall St. · 3d ago CVS Health and Aetna Help Florida City Families Prepare for the School Year at Branches' Back to School Night ACCESS Newswire · 3d ago

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.